Skip to content

Immune response to pandemische influenza A/H1N1 vaccination in the immunocompromised.

Immune response to pandemische influenza A/H1N1 vaccination in the immunocompromised. - RICH -3

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON32477
Enrollment
195
Registered
2009-10-30
Start date
2009-11-03
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

flu influenza

Interventions

None listed

Sponsors

Leids Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: -

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

MeasureTime frame
-

Secondary

MeasureTime frame
-

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)